Back to News
Market Impact: 0.3

Renalytix shares climb 24% as two-year kidney study data published

Company FundamentalsProduct LaunchesTechnology & Innovation
Renalytix shares climb 24% as two-year kidney study data published

Renalytix PLC shares jumped 24% to 2.35p after the company published two-year precision-diagnostics data. The news provides positive support for the durability/track record of its diagnostic offering, driving near-term upside sentiment for the stock.

Analysis

Renalytix PLC shares jumped 24% to 2.35p after the company published two-year precision-diagnostics data. The news provides positive support for the durability/track record of its diagnostic offering, driving near-term upside sentiment for the stock.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request Demo

Market Sentiment

Overall Sentiment

mildly positive

Sentiment Score

0.35

Ticker Sentiment

RENX0.60
RNLXY0.60

More News